Karuna Therapeutics, Inc. (KRTX): Price and Financial Metrics
GET POWR RATINGS... FREE!
KRTX Stock Price Chart Interactive Chart >
KRTX Price/Volume Stats
|Current price||$107.51||52-week high||$161.98|
|Prev. close||$106.63||52-week low||$92.26|
|Day high||$112.00||Avg. volume||222,925|
|50-day MA||$118.65||Dividend yield||N/A|
|200-day MA||$119.54||Market Cap||3.21B|
Karuna Therapeutics, Inc. (KRTX) Company Bio
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company develops treatments for people afflicted with schizophrenia. Karuna Therapeutics was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.
Most Popular Stories View All
KRTX Latest News Stream
|Loading, please wait...|
KRTX Latest Social Stream
View Full KRTX Social Stream
Latest KRTX News From Around the Web
Below are the latest news stories about Karuna Therapeutics Inc that investors may wish to consider to help them evaluate KRTX as an investment opportunity.
The following slide deck was published by Karuna Therapeutics, Inc. in conjunction with this event....
Karuna Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides General Business Update
BOSTON, February 24, 2022--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced financial results for the fourth quarter and full year ended December 31, 2021, and provided a general business update.
Analysts say company is taking novel approach to treating mental illnesses, Alzheimer's
Viewing insider transactions for Karuna Therapeutics, Inc.'s ( NASDAQ:KRTX ) over the last year, we see that insiders...
Leola, PA, based Investment company Emerald Mutual Fund Advisers Trust (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, Karuna Therapeutics Inc, HireRight Holdings Corp, sells Chegg Inc, BellRing Brands Inc, Echo Global Logistics Inc, Tetra Tech Inc, ORIC Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Mutual Fund Advisers Trust.
KRTX Price Returns